Showing results (1301-1310 of 1,994) with videos related to

Sort By:
Pageof 200
Annals of Surgical Oncology|June 7, 2017
Disease Progression in Papillary Thyroid Cancer with Biochemical Incomplete Response to Initial TherapyNicole K Zern, Roderick Clifton-Bligh, Anthony J Gill, et al.
Histopathology|October 31, 2020
Chromosomal imbalances detected in NTRK-rearranged sarcomas by the use of comparative genomic hybridisationAna Cristina Vargas, Nima M Ardakani, Daniel D Wong, et al.
HIV Medicine|July 4, 2015
Opioid use and risk of liver fibrosis in HIV/hepatitis C virus-coinfected patients in CanadaL Brunet, E E M Moodie, J Cox, et al.
Science (New York, N.Y.)|June 19, 1992
Hydrogen exchange measurement of the free energy of structural and allosteric change in hemoglobinS W Englander, J J Englander, R E McKinnie, et al.
Journal of Acquired Immune Deficiency Syndromes|September 1, 1994
Safety profile of didanosine among patients with advanced HIV disease who are intolerant to or deteriorate despite zidovudine therapy: results of the Canadian Open ddI Treatment ProgramJ S Montaner, A Rachlis, R Beaulieu, et al.
The Tohoku Journal of Experimental Medicine|May 1, 1994
Lymphocyte membrane modifications induced by HIV infectionN Kashiwagi, M J Gill, M Adachi, et al.
Tissue Antigens|October 22, 2009
Successful implementation of a national HLA-B*5701 genetic testing service in CanadaR G Lalonde, R Thomas, A Rachlis, et al.
Endocrine-Related Cancer|February 17, 2009
Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomasP S H Soon, A J Gill, D E Benn, et al.
AIDS and Behavior|September 23, 2009
Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in ChinaLora L Sabin, Mary Bachman DeSilva, Davidson H Hamer, et al.
The Journal of Infectious Diseases|October 1, 1991
Randomized, double-blind, placebo-controlled, clinic-initiated, Canadian multicenter trial of topical edoxudine 3.0% cream in the treatment of recurrent genital herpes. Canadian Cooperative Study GroupS L Sacks, L D Tyrrell, D Lawee, et al.
Pageof 200